Two different large scale studies recently measured C-Alb and HCit among participants of the Chronic Renal Insufficiency Cohort (CRIC) study, providing a unique opportunity to now compare head-to-head the operating characteristics and prognostic utility of two of the most widely used markers of carbamylation in clinical investigation [20, 21]. This evidence concerns the gene ALB and chronic kidney disease.